Kirk A. Christoffersen

Kirk A. Christoffersen

Plus aucun poste en cours
58 ans
Health Technology
Consumer Services
Commercial Services

Profil

Kirk A. Christoffersen formerly worked at Gilead Sciences, Inc., as Associate Director-Corporate Development in 2002, OSI Pharmaceuticals, Inc., as Manager-Gelclair Brand in 2004, Sirna Therapeutics, Inc., as Principal, Compugen Ltd., as Senior VP-Corporate & Business Development from 2016 to 2020, GlobeImmune, Inc., as Vice President-Corporate Development from 2004 to 2015, Arch Oncology, Inc., as Chief Business Officer, and FibroGen, Inc., as Chief Business Officer from 2020 to 2024.
Mr. Christoffersen received his undergraduate degree in 1990 from the University of Michigan and Masters Business Admin degree in 1993 from Daniels College of Business.

Anciens postes connus de Kirk A. Christoffersen

SociétésPosteFin
KYNTRA BIO, INC. Corporate Officer/Principal 01/12/2024
COMPUGEN LTD. Corporate Officer/Principal 08/01/2020
GLOBEIMMUNE, INC. Corporate Officer/Principal 03/08/2015
OSI PHARMACEUTICALS, INC. Corporate Officer/Principal 01/01/2004
GILEAD SCIENCES, INC. Corporate Officer/Principal 01/01/2002
Voir l'expérience en détail de Kirk A. Christoffersen

Formation de Kirk A. Christoffersen

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

99

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

  1. Bourse
  2. Insiders
  3. Kirk A. Christoffersen
-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT
🔇